PAREXEL Strengthens Commitment to Global Biopharmaceutical Workforce
News Apr 10, 2015
PAREXEL International Corporation has announced three new academic programmes at the PAREXEL Academy. The offerings span the globe and are designed to prepare students for careers in the biopharmaceutical industry:
• Bachelor of Science Degree in Clinical Research - Offered in partnership with the Medical School Berlin, in Berlin, Germany, the degree programme features courses specific to clinical research. Courses range from ethics in health and medicine to conducting clinical trials. Several courses are taught by PAREXEL experts.
• Postgraduate Certificate in Clinical Trial Management - In cooperation with Salem State University in Salem, Massachusetts, the postgraduate certificate programme features a broad-based curriculum in various components of the full life cycle of drug development.
• Joint Programme for Clinical Research and Clinical Trial Management - In collaboration with Kyoto Pharmaceutical University in Kyoto, Japan, the joint programme provides fifth grade undergraduate students an introductory, seven-week course in clinical research and clinical trial management.
"PAREXEL is committed to developing the biopharmaceutical industry's next-generation global workforce," said Heidrun Bruchmann, Ph.D., Senior Director, PAREXEL Academy. "Through the PAREXEL Academy, we tailor educational and degree programmes with our partners to equip the future health sciences workforce with a holistic and cross-functional foundation in clinical research and clinical trial management."
For more than a decade, the PAREXEL Academy has designed and implemented a wide range of learning programmes tailored to enable clinical research management practices for learners inside and outside of PAREXEL. The PAREXEL Academy has locations in the United States, Europe, and Asia. Since inception, approximately 1,000 students have graduated from the Academy's programmes, including its undergraduate Bachelor of Science programme.
Mary L. Churchill, Ph.D. Associate Provost, Innovation and Partnerships, Salem State University, commented that "Salem State is committed to providing students with programmes that are both foundational and workforce-aligned. Through our partnership with the PAREXEL Academy, we create programmes to give students the specific tools needed to succeed post-graduation in biopharmaceutical research."
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Researchers Find a Way to Separate Side Effects of Opioid Drugs Reducing RiskNews
Scientists have discovered a way to separate these two effects -- pain relief and breathing, opening a window of opportunity to make effective pain medications without the risk of respiratory failure.READ MORE